COMMUNIQUÉS West-GlobeNewswire

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)
01/10/2026
LGSOC is a biologically distinct variant of ovarian cancer, with limited treatment options, that is generally less responsive to conventional chemotherapy Results presented in a late-breaking plenary session at IGCS [...]
NMDP Gala Highlights Financial Challenges Facing Patients in Need of Blood Stem Cell Transplants
01/10/2026
Patient financial assistance requests are up 34% as NMDP and its supporters work to help more families overcome barriers to treatment MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- With demand for financial assistance [...]
IBA SA – NOTIFICATION TRANSPARENCE
01/10/2026
(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 1 octobre 2026, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le [...]
IBA – TRANSPARENCY NOTIFICATION
01/10/2026
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, October 1, 2026 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]
Coloplast A/S - Major shareholder announcement
01/10/2026
Major shareholder announcement Reference is made to the press release issued by Coloplast A/S on 4 September 2026 regarding the expected implementation of the generational change in the ultimate ownership of Coloplast A [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
01/10/2026
Please see enclosed pdf. Attachment 01102026_trading_in_shares_Coloplast_Fonden
Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya
01/10/2026
September 29 shipment follows successful customer inspection and approximately $1.77 million in customer payments received MANKATO, Minn., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. (OTC: EZES [...]
Health-ISAC® Director of European Operations Elected European Council of ISACs Chair
01/10/2026
Vasileios Mingos to lead cross-sector cyber and physical resilience initiatives across European critical infrastructure networks BRUSSELS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center [...]
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
01/10/2026
PETACH TIKVA, Israel, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment [...]
Nox Peptides Announces Expanded Research Focus on BPC-157 and GHK-Cu in Canada
01/10/2026
Toronto, ON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nox Peptides has announced an expanded focus on research-use peptide compounds in Canada, highlighting BPC-157 and GHK-Cu as part of its ongoing efforts to support [...]
Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma
01/10/2026
Annual program will award funding to early-career healthcare professionals advancing research, education, and innovation in multiple myeloma BRIDGEWATER, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech [...]
Legato Frames, the World’s First AI-Based Hearing Glasses, Are Now Available in the U.S.
01/10/2026
Designed for the millions of adults seeking a better alternative to traditional hearing aids, Legato Frames integrate AI-powered sound processing into stylish eyewear built for everyday life. BOSTON, Oct. 01, 2026 ( [...]
Vima Therapeutics to Present New Research at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
01/10/2026
Four presentations highlight significant treatment gaps in isolated dystonia and new research providing mechanistic rationale for targeting muscarinic cholinergic receptors for treating movement disorders BOSTON, Oct. [...]
AONN+ and Manta Cares Partner to Equip Oncology Navigators With AI Tool Purpose-Built for Cancer Patients
01/10/2026
The collaboration provides training, education, and safe AI resources to more than 9,000 oncology nurse and patient navigators nationwide as patients increasingly turn to general purpose AI for cancer information SAN [...]
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
01/10/2026
CARLSBAD, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
01/10/2026
CINCINNATI, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2026, on Tuesday, October 27, 2026, following [...]
Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
01/10/2026
Oral presentation will highlight previously reported data demonstrating early stabilization or improvement in mFARS scores among LX2006-treated participants compared with propensity-matched control cohort from UNIFAI [...]
Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)
01/10/2026
Application represents an important step in supporting reimbursement Company remains on track for U.S. commercial launch of LYTENAVA before year-end 2026 ISELIN, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Outlook [...]
AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data
01/10/2026
Recent biotech media features focus on Ampligen’s potential to address immune resistance in metastatic pancreatic cancer and the clinical progress of the Phase 2 DURIPANC program OCALA, Fla., Oct. 01, 2026 (GLOBE [...]

Pages